Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883

Rank in Stocks #26515
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Share Price
$0.1875979
Last synced: 2026-11-13
Market Cap
$19.43M
Change (1 day)
10.97%
Change (1 year)
-58.58%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Modalis Therapeutics Corporation (4883)

Category

Healthcare
Operating Margin for Modalis Therapeutics Corporation (4883)
Operating Margin as of November 2026 TTM: 0.00%
According to Modalis Therapeutics Corporation's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Modalis Therapeutics Corporation from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% -100.00%
2022 -5,094.31% -95.48%
2021 -112,676.73% 96,634.83%
2020 -116.48% -577.77%
2019 24.38% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Modalis Therapeutics Corporation's operating margin

What was Modalis Therapeutics Corporation's operating margin in 2025?

In 2025, Modalis Therapeutics Corporation's operating margin was 0.00%, compared with 0.00% in 2024.

How has Modalis Therapeutics Corporation's operating margin changed since 2020?

From 2020 to 2025, Modalis Therapeutics Corporation's operating margin was highest in 2025 (0.00%) and lowest in 2021 (-112,676.73%).

How does Modalis Therapeutics Corporation's operating margin compare with similar companies?

Modalis Therapeutics Corporation's operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.